$TXN — AVOID 📊 | 6 MONTHS THESIS

$TXN — AVOID 📊 | 6 MONTHS THESIS 🎯 Q1 2026 | Rev $4.8B | EPS $1.71 vs $1.37 🟢 | Margin 37.5% 💡 Consensus appears to extrapolate the recent beat into sustained high growth without adequate discounting for cyclical risk. The market-implied 13.5% FCF growth forever is too aggressive; a reversion to historical P/E (28x) would erode value. 📉 Reward/risk: 0.5:1 🏢 Business Quality: 9/10 - Best-in-class analog semiconductor franchise with wide moat, high margins, and strong capital returns, but stock price does not reflect business quality at current levels. 📊 Valuation: rich — assessed via multiple methods: P/E (51.6x vs historical range 25.1x-33.7x and peer band 8.5x-19.1x); reverse DCF (implies 13.5% FCF growth,... 🔮 Catalyst: Post-earnings drift with no near-term catalysts; risk of downward estimate revisions or macro headwinds 📊 Our read: AVOID. Full analysis → https://stockduty.xyz/s/TXN0624

🎯 Q1 2026 | Rev $4.8B | EPS $1.71 vs $1.37 🟢 | Margin 37.5%